1. 791OUpdated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up. (23rd October 2018) Authors: Fizazi, K; Carmel, A; Joly, F; Delva, R; Gravis, G; Rolland, F; Priou, F; Ferrero, J-M; Houede, N; Mourey, L; Theodore, C; Krakowski, I; Berdah, J-F; Baciuchka Palmaro, M; Laguerre, B; Flechon, A; Ravaud, A; Brihoum, M; Culine, S; Le Teuff, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 870PDEfficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap). (23rd October 2018) Authors: Negrier, S; Rioux-Leclercq, N; Ravaud, A; Gravis, G; Geoffrois, L; Chevreau, C M; Rolland, F; Blanc, E; Segura-Ferlay, C; Perol, D; Gross Goupil, M; Dermeche, S; Flechon, A; Albiges, L; Escudier, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗